Capital World Investors 13D/13G Filings for Vertex Pharmaceuticals Incorporated (VRTX)

Capital World Investors 13D and 13G filings for Vertex Pharmaceuticals Incorporated:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-04-10
12:14 pm
Purchase
2024-04-1013GVertex Pharmaceuticals Incorporated
VRTX
Capital World Investors25,902,938
10.000%
3,822,731increase
(+17.31%)
Filing
2024-02-09
6:19 pm
Purchase
2024-02-0713GVertex Pharmaceuticals Incorporated
VRTX
Capital World Investors22,080,207
8.600%
9,140,888increase
(+70.64%)
Filing
2023-02-13
2:49 pm
Purchase
2023-02-1413GVertex Pharmaceuticals Incorporated
VRTX
Capital World Investors12,939,319
5.000%
5,564,740increase
(+75.46%)
Filing